HomeDiscoveryOncology seminarsOncology seminars 2008

Oncology seminars 2008


December, 12 2008 (13:30-14:30 PM)
Genomics of uveal melanoma: prognosis and target identification
Ulrich Pfeffer
National Cancer Research Institute
Genova, Italy

November, 21 2008 (1:30-2:30 PM)
Lanthanide complexes for sensing and imaging: magnetic resonance and emission probes
David Parker
Department of Chemistry
Durham University, UK

November, 14 2008 (1:30-2:30PM)
The impact of pharmacogenomics and pharmacokinetic on drug efficacy and drug toxicity
Prof Mauro Magnani
Istituto di Chimica Biologica "G. Fornaini",Università degli Studi "Carlo Bo"

November, 7 2008
The CD38/NAD+/Cyclic ADP-ribose/intracellular calcium signalling pathway: mechanisms and therapeutic outlook
Antonio De Flora
Department of Experimental Medicine Center of Excellence for Biomedical Research of Genova

October, 24 2008 (1:30-2:30 PM)
From Mad Cow Disease to Sepsis: how NMR can help
Luigi Calzolai
Medway School of Pharmacy, Universities of Kent and Greenwich at Medway
Chatham Maritime,Kent

October, 17 2008 (10:00-11:00 )
T-cell gene manipulation by chimeric TcR for innovative treatment of acute leukemia
Andrea Biondi
Dipartimento di Medicina Clinica e Prevenzione Direttore, Centro Ricerca M. Tettamanti
Monza (Italy)

October, 10 2008 (1:30-2:30 PM)
Molecular imaging modalities in translational cancer research
Boudewijn Lelieveldt
Division of Image Processing,Department of Radiology,Leiden University Medical Center
Leiden, The Netherlands

September, 26 2008 (1:30-2:30PM)
Cancer mutations and targeted therapies
Alberto Bardelli
Laboratory of Molecular Genetics-The Oncogenomics Center, Institute for Cancer Research and Treatment (IRCC)
Candiolo (Torino)

September, 12 2008 (1:30-2:30 PM)
Leucemia acuta mieloide con mutazione della nucleophosmina:aspetti biologici e clinici
Brunangelo Falini
Institute of Hematology University of Perugia

September, 5 2008 (1:30-2:30PM)
The petidyl prolyl isomerase Pin1 is a novel pharmacological target in cancer therapy: enhanced responses of acute myeloid leukemia cells to retinoids
Enrico Garattini
Laboratory of Molecular Biology,Istituto di Ricerche Farmacologiche "Mario Negri"
Via La Masa, 19 Milano

July, 18 2008 (1:30-2:30 PM)
Mode and dynamics of protein-DNA interactions at a human replication origin
Arturo Falaschi
Professore di Biologia Molecolare Scuola Normale Superiore

July, 4 2008 (1:30- 2:30 PM)
Mutations of NPM in Acute Myeloid Leukemia
Emanuela Colombo

June, 27 2008 (11:30-12:30 PM)
Therapeutic potential of cancer stem cells from solid tumors
Ruggero De Maria
Isituo Superiore Sanità

June, 20 2008 (1:30-2:30 PM)
Polyamines: old molecules, new syntheses, new opportunities. The multicomponent reactions protagonist in the medicinal chemistry
Gian Cesare Tron
Dipartimento di Scienze Chimiche, Alimentari, Farmaceutiche e Farmacologiche and Drug and Food Biotechnology Center
Università Studi del Piemonte Orientale A. Avogadro-Novara

May, 30 2008 (1:30-2:30 PM)
CDC25 phosphatases. Cell cycle regulators and therapeutic targets
Bernard Ducommun
Institut d'Exploration Fonctionnelle des Génomes

May, 23 2008 (1:30- 2:30 PM)
Targeting breast cancer: from the benchside to the bed and vice versa
Giancarlo Pruneri
Division of Pathology and Laboratory Medicine European Institute of Oncology

May, 16 2008 (1:30-2:30 PM )
The role of the human mismatch repair system in drug resistance
Josef Jiricny
Institute of Molecular Cancer Research,University of Zürich

May, 9 2008 (1:30-2:30 PM)
Vascuar tumor targeting: from the bench to the clinic
Dario Neri
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology, Zurich

April, 2 2008 (2:30-3:30 PM)
The ubiquitin-dependent chaperone VCP/p97/Cdc48 regulates Aurora-B activity on mitotic chromatin
Hemmo Meyer
ETH Swiss Federal Institute of Technology

February, 1 2008 (1:30- 2:30 PM)
Cancer mortality trends in the European Union: priorities for cancer control
Carlo La Vecchia
Head, Laboratory of General Epidemiology,Istituto di Ricerche Farmacologiche "Mario Negri"